← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 1, 2014Last known activity
Jan 31, 2024
Timeline
2010s
- Jan 1, 2012
German Center for Infection Research— Founded
Drugs by trial phase (18 distinct, 12 trials)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT05727267CollaboratorPhase 1Jan 31, 2024
- NCT06114628CollaboratorPhase 2Dec 8, 2023
- NCT05226390CollaboratorPhase 1Feb 24, 2022
- NCT04895449CollaboratorPhase 1Jul 16, 2021
- NCT05950776CollaboratorPhase 2Jan 15, 2021
- NCT04569383CollaboratorPhase 1Oct 5, 2020
- NCT04119440CollaboratorPhase 1May 31, 2020
- NCT03818308CollaboratorPhase 2May 28, 2019
- NCT03590600CollaboratorPhase 1Jun 7, 2018
- NCT03282474CollaboratorPhase 2Dec 7, 2017
- NCT02704533CollaboratorPhase 1Sep 1, 2016
- NCT02283099CollaboratorPhase 1Nov 1, 2014
Details
- Founded
- Braunschweig, DE Jan 1, 2012
- Last known activity
- Jan 31, 2024